Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Eli lilly and company symbols : BNTX save search
Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period (2019-2032), Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo
Published: 2023-10-04 (Crawled : 21:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
RVMD | $35.56 -1.93% -1.97% 1.2M
|
Health Technology
|
| O: -0.58%
H: 4.83%
C: 4.38%
IOVA 4 | $11.69 -1.43% -1.45% 2.7M
|
Health Technology
|
| O: 0.24%
H: 3.66%
C: 1.95%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -0.44%
H: 1.52%
C: 0.08%
AXSM | $71.23 -2.53% -2.6% 580K
|
Health Technology
|
| O: -0.43%
H: 4.97%
C: 4.71%
lung companies cancer study market
Head and Neck Squamous Cell Carcinoma Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Pfizer, Merck, Eisai, AstraZeneca, Innate, Roche, GlaxoSmithKline, BeiGene, IO Biotech, Incyte
Published: 2023-09-18 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: -1.16%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.06%
H: 1.19%
C: 0.58%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.09%
H: 1.16%
C: 1.16%
MRUS | $41.96 2.79% 2.72% 740K
|
Health Technology
|
| O: -0.16%
H: 2.46%
C: 0.56%
KURA | News | $18.76 0.16% 0.16% 670K
|
Health Technology
|
| O: -0.1%
H: 2.4%
C: 0.52%
IOVA 4 | $11.69 -1.43% -1.45% 2.7M
|
Health Technology
|
| O: -0.51%
H: 1.5%
C: -7.97%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.03%
H: 2.18%
C: 1.8%
FUSN | $21.4 -0.09% -0.09% 270K
|
Health Technology
|
| O: 0.0%
H: 0.41%
C: -2.26%
CALT | $18.5 1.65% 1.62% 1.5K
|
Health Technology
|
| O: -6.2%
H: 4.2%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -0.01%
H: 1.99%
C: 1.28%
companies cell growth market
Triple-Negative Breast Cancer Market to Accelerate Substantially During the Forecast Period (2023-2032), Examines DelveInsight | Key Companies to Watch - Roche, AbbVie, AstraZeneca, BeiGene, GlaxoSmithKline, Genentech, Eli Lilly, Novartis
Published: 2023-09-06 (Crawled : 21:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.76%
H: 2.15%
C: 1.6%
RCUS 4 | $15.43 -0.45% 0.0% 520K
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: -4.96%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
IOVA 4 | $11.69 -1.43% -1.45% 2.7M
|
Health Technology
|
| O: -1.5%
H: 0.83%
C: -1.69%
IMMP | $2.59 3.19% 3.09% 1.4M
|
Health Technology
|
| O: 0.53%
H: 0.53%
C: 0.53%
GTHX | $3.98 -5.01% -5.28% 340K
|
Health Technology
|
| O: -0.6%
H: 1.2%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -1.16%
H: 1.14%
C: 0.89%
companies breast cancer novartis market
Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim
Published: 2023-08-03 (Crawled : 21:00) - prnewswire.com
BMEA | $10.76 -2.0% -2.04% 850K
|
Professional, Scientific, and T...
|
| O: -0.11%
H: 4.35%
C: 1.85%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
RCUS 4 | $15.43 -0.45% 0.0% 520K
|
Health Technology
|
| O: 0.11%
H: 1.42%
C: -0.16%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 2.43%
H: 0.0%
C: 0.0%
MRUS | $41.96 2.79% 2.72% 740K
|
Health Technology
|
| O: -0.23%
H: 1.85%
C: 0.15%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.8%
H: 0.99%
C: -1.29%
GRTX | $0.1821 -6.13% -6.53% 810K
|
Health Technology
|
| O: 0.45%
H: 4.02%
C: 0.45%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -0.01%
H: 1.23%
C: -0.15%
AGEN A | $7.42 14.86% 12.94% 1.3M
|
Health Technology
|
| O: 0.69%
H: 3.08%
C: 0.0%
companies expected pancreatic tumor endocrine growth market
Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published: 2023-06-08 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: -1.7%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: -0.62%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.62%
H: 0.88%
C: 0.81%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.26%
H: 1.08%
C: 0.91%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.41%
H: 0.68%
C: 0.64%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.11%
H: 2.66%
C: 2.24%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.28%
H: 0.42%
C: -0.05%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.39%
H: 0.15%
C: -0.79%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.23%
H: 1.83%
C: 1.52%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.0%
H: 0.28%
C: -0.23%
metabolic report cancer global therapeutics growth market
CAR-T Cell Therapy Market Size to Reach USD 9.62 Million in 2030| Emergen Research
Published: 2023-01-09 (Crawled : 16:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 3.12%
H: 0.0%
C: -2.55%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 0.58%
H: 0.44%
C: -0.31%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.76%
H: 0.26%
C: -3.27%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.29%
H: 0.27%
C: -3.89%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.16%
H: 0.05%
C: -2.89%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 1.42%
H: 0.64%
C: -2.27%
research car-t therapy market
Propulsion of Pancreatic Cancer Pipeline as Novel and Extensive 170+ Therapies Likely to Enter in the Treatment Domain | DelveInsight
Published: 2023-01-02 (Crawled : 16:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
| Email alert
Add to watchlist
RCUS 4 | $15.43 -0.45% 0.0% 520K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
QLGN | $0.296 -6.03% -6.42% 24K
|
Health Technology
| Email alert
Add to watchlist
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
| Email alert
Add to watchlist
AGEN A | $7.42 14.86% 12.94% 1.3M
|
Health Technology
| Email alert
Add to watchlist
MRUS | $41.96 2.79% 2.72% 740K
|
Health Technology
| Email alert
Add to watchlist
GRTX | $0.1821 -6.13% -6.53% 810K
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
| Email alert
Add to watchlist
treatment cancer pancreatic
Biotech Sector Gaining Wins Against Pancreatic Cancer with Early Detection and New Therapies
Published: 2022-11-14 (Crawled : 16:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.92%
H: 0.48%
C: -0.84%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.83%
H: 1.63%
C: -0.26%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 3.64%
H: 0.58%
C: -7.6%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -1.61%
H: 6.39%
C: 5.49%
biotech cancer pancreatic
DelveInsight Evaluates a Robust RNA Interference Pipeline as Key 85+ Pharma Companies Set Foot in the RNA Interference Space
Published: 2022-11-01 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 7.74%
H: 0.17%
C: 0.17%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -4.49%
H: 3.81%
C: 1.95%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 2.95%
H: 2.66%
C: -0.1%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: 1.1%
H: 3.4%
C: -1.36%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 4.54%
H: 4.25%
C: 0.13%
ALNY | $143.8 -1.55% -1.58% 390K
|
Health Technology
|
| O: 1.06%
H: 2.53%
C: 1.75%
space pharma companies set
Better Together: New Licensing and Collaboration Deals to Watch
Published: 2022-04-11 (Crawled : 16:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.45%
H: 0.21%
C: -1.32%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -2.44%
H: 3.61%
C: 2.68%
collaboration license
PFIZER REPORTS THIRD-QUARTER 2021 RESULTS
Published: 2021-11-02 (Crawled : 13:00) - biospace.com/
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 1.14%
H: 0.94%
C: -1.98%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.58%
H: 0.42%
C: 0.24%
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: 3.46%
H: 0.7%
C: -0.09%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 2.06%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 1.16%
H: 0.75%
C: -0.19%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.13%
H: 3.09%
C: 2.62%
ARVN | $32.51 -4.38% -4.58% 470K
|
Health Technology
|
| O: 1.4%
H: 4.09%
C: 4.07%
results
AC Immune Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-08-04 (Crawled : 12:00) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.0%
H: 5.72%
C: 2.53%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 2.61%
H: 20.19%
C: 14.8%
ACIU | $2.33 -2.1% -2.15% 320K
|
Health Technology
|
| O: -1.54%
H: 4.56%
C: 0.0%
financial results results
Pfizer Reports Second-quarter 2021 Results
Published: 2021-07-28 (Crawled : 12:00) - biospace.com/
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: -0.29%
H: 3.68%
C: 2.6%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.59%
H: 3.28%
C: 2.6%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.09%
H: 2.07%
C: 1.29%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 1.76%
H: 9.05%
C: 8.46%
ARVN | $32.51 -4.38% -4.58% 470K
|
Health Technology
|
| O: 1.33%
H: 10.82%
C: 8.97%
results
PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: -0.07%
H: 1.11%
C: -0.67%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.43%
H: 0.43%
C: -0.13%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.87%
H: 1.36%
C: 0.36%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 1.72%
H: 0.31%
C: -16.76%
results report
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.